Alpha Centric Advisors LLC Aclaris Therapeutics, Inc. Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
SELL
$13.07 - $18.22 $888,760 - $1.24 Million
-68,000 Closed
0 $0
Q4 2021

Feb 25, 2022
BUY
$12.27 - $18.49 $208,590 - $314,330
17,000 Added 33.33%
68,000 $989,000
Q3 2021

Mar 09, 2022
BUY
$13.38 - $18.8 $187,320 - $263,200
14,000 Added 37.84%
51,000 $918,000
Q2 2021

Mar 09, 2022
BUY
$17.08 - $29.6 $631,959 - $1.1 Million
37,000 New
37,000 $650,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $242M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email